ZNF528 and Andersen-Tawil syndrome: During the progression of CMs (day 4 to day 30) in the mutation group, ZNF528 with reduced accessibility was related to pathogenicity in heterogeneous modules and its continuous low expression might affect the downstream target genes associated with LQT7 symptoms.